Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-Obinutuzumab Polyclonal Antibody

😃Good
Catalog No. TMAS-00063
Alias Gazyva

Anti-Obinutuzumab Polyclonal Antibody is a Rabbit antibody targeting Obinutuzumab. Anti-Obinutuzumab Polyclonal Antibody can be used in ELISA.

Anti-Obinutuzumab Polyclonal Antibody

Anti-Obinutuzumab Polyclonal Antibody

😃Good
Catalog No. TMAS-00063Alias Gazyva
Anti-Obinutuzumab Polyclonal Antibody is a Rabbit antibody targeting Obinutuzumab. Anti-Obinutuzumab Polyclonal Antibody can be used in ELISA.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
40 μg$6097-10 days7-10 days
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Anti-Obinutuzumab Polyclonal Antibody is a Rabbit antibody targeting Obinutuzumab. Anti-Obinutuzumab Polyclonal Antibody can be used in ELISA.
SynonymsGazyva
Ig Type
IgG
Specificity
The product is specific for Obinutuzumab. This antibody serves as an excellent positive control for Obinutuzumab immunogenicity (ADA) assays.
Application
Recommended Dose
ELISA: 0.005-1 µg/ml
Antibody Type
Polyclonal
Host SpeciesRabbit
PurificationAntigen affinity purification
AppearanceLyophilized. Reconstitute the lyophilized powder with deionized water (or equivalent) to a final concentration of 0.5 mg/mL.
FormulationLyophilized with PBS, pH 7.4, containing 0.02% sodium azide.
Research BackgroundObinutuzumab is a humanized anti-CD20 monoclonal antibody, originated by GlycArt Biotechnology AG and developed by Roche as a cancer treatment. It was approved under the trade name Gazyva by the US FDA in 2013, and as Gazyvaro by the EMA in Europe, for the treatment of chronic lymphocytic leukemia in combination with chemotherapy in treatment-naive patients, and as a second line treatment for follicular lymphoma. Obinutuzumab is a fully humanized monoclonal antibody that binds to an epitope on CD20 that partially overlaps with the epitope recognized by rituximab. Obinutuzumab binds to CD20 on B cells and causes these cells to be destroyed by engaging the adaptive immune system, directly activating intracellular apoptosis pathways, and activating the complement system.
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Immunogen
Obinutuzumab
Chemical Properties
Stability & Storage
Stability & StorageThe lyophilized product store at -20°C or -80°C for 12 months. The reconstituted antibody can be stored at 2°C-8°C for 2-3 weeks or at -20°C for 12 months. Avoid repeated freeze-thaw cycles.
TransportShipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Anti-Obinutuzumab Polyclonal Antibody | purchase Anti-Obinutuzumab Polyclonal Antibody | Anti-Obinutuzumab Polyclonal Antibody cost | order Anti-Obinutuzumab Polyclonal Antibody